HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Baorui Liu Selected Research

Chimeric Antigen Receptors

5/2024Acidity-targeting transition-aided universal chimeric antigen receptor T-cell (ATT-CAR-T) therapy for the treatment of solid tumors.
7/2023Combination therapy of DKK1 inhibition and NKG2D chimeric antigen receptor T cells for the treatment of gastric cancer.
1/2023Nanomodified Switch Induced Precise and Moderate Activation of CAR-T Cells for Solid Tumors.
1/2022In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors.
10/2021Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Baorui Liu Research Topics

Disease

195Neoplasms (Cancer)
12/2024 - 10/2007
70Stomach Neoplasms (Stomach Cancer)
12/2024 - 10/2007
22Neoplasm Metastasis (Metastasis)
03/2024 - 04/2008
15Lung Neoplasms (Lung Cancer)
01/2024 - 09/2008
15Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 04/2012
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 11/2009
14Pancreatic Neoplasms (Pancreatic Cancer)
01/2024 - 05/2009
11Breast Neoplasms (Breast Cancer)
04/2024 - 04/2008
11Hepatocellular Carcinoma (Hepatoma)
04/2024 - 01/2013
11Disease Progression
03/2024 - 03/2012
11Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2022 - 02/2016
9Adenocarcinoma
01/2023 - 06/2013
9Melanoma (Melanoma, Malignant)
11/2022 - 11/2012
7Carcinoma (Carcinomatosis)
10/2022 - 08/2010
6Liver Neoplasms (Liver Cancer)
07/2023 - 02/2011
5Inflammation (Inflammations)
11/2023 - 04/2013
5Signet Ring Cell Carcinoma
01/2023 - 01/2014
5Colonic Neoplasms (Colon Cancer)
01/2020 - 02/2011
4Cholangiocarcinoma
03/2024 - 01/2021
4Malignant Pleural Effusion
03/2024 - 01/2012
4Testicular Neoplasms (Testicular Cancer)
11/2023 - 05/2019
4Circulating Neoplastic Cells
01/2020 - 03/2014
4Ascites
01/2019 - 09/2008
4Nasopharyngeal Carcinoma
01/2018 - 11/2016
4Carcinogenesis
01/2017 - 05/2009
4Hyperthermia
01/2012 - 06/2007
3Hematologic Neoplasms (Hematological Malignancy)
07/2023 - 10/2017
3Hypertension (High Blood Pressure)
12/2021 - 04/2013
3Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 01/2013
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2021 - 03/2008

Drug/Important Bio-Agent (IBA)

35Biomarkers (Surrogate Marker)IBA
01/2024 - 04/2008
27Peptides (Polypeptides)IBA
12/2024 - 12/2011
22Docetaxel (Taxotere)FDA Link
06/2022 - 06/2007
21Messenger RNA (mRNA)IBA
07/2022 - 03/2008
19AntigensIBA
04/2024 - 01/2017
18Immune Checkpoint InhibitorsIBA
12/2023 - 06/2017
17VaccinesIBA
12/2024 - 01/2018
16Proteins (Proteins, Gene)FDA Link
07/2024 - 11/2010
16Paclitaxel (Taxol)FDA LinkGeneric
12/2021 - 08/2008
13Cisplatin (Platino)FDA LinkGeneric
03/2020 - 03/2008
11LigandsIBA
07/2024 - 01/2016
11Recombinant ProteinsIBA
03/2022 - 02/2015
10HydrogelsIBA
07/2024 - 01/2018
10ErbB Receptors (EGF Receptor)IBA
03/2022 - 01/2013
9Antineoplastic Agents (Antineoplastics)IBA
11/2022 - 06/2007
8NanovaccinesIBA
12/2024 - 01/2022
8gambogic acidIBA
05/2024 - 04/2008
7Neoplasm Antigens (Tumor Antigens)IBA
05/2024 - 01/2017
7CytokinesIBA
03/2024 - 01/2018
7Monoclonal AntibodiesIBA
03/2024 - 01/2013
7Cancer VaccinesIBA
02/2024 - 05/2019
7Therapeutic UsesIBA
11/2023 - 06/2013
7Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 - 10/2007
6Programmed Cell Death 1 ReceptorIBA
12/2023 - 01/2020
6ParaffinIBA
07/2022 - 09/2011
6GelatinasesIBA
06/2022 - 11/2012
6MicroRNAs (MicroRNA)IBA
01/2020 - 08/2010
6Pemetrexed (MTA)FDA Link
01/2017 - 11/2012
5Chimeric Antigen ReceptorsIBA
05/2024 - 10/2021
5Irinotecan (Camptosar)FDA LinkGeneric
01/2023 - 01/2013
5Formaldehyde (Formol)FDA Link
07/2022 - 09/2011
5GemcitabineFDA Link
01/2022 - 05/2011
5Fluorouracil (Carac)FDA LinkGeneric
03/2017 - 03/2008
5tetrandrineIBA
02/2012 - 10/2007
4EpitopesIBA
12/2024 - 01/2022
4Imiquimod (Aldara)FDA LinkGeneric
04/2024 - 11/2021
4Tyrosine Kinase InhibitorsIBA
01/2024 - 05/2016
4sintilimabIBA
01/2024 - 01/2021
4Doxorubicin (Adriamycin)FDA LinkGeneric
10/2023 - 03/2009
4salinomycinIBA
06/2022 - 01/2018
4Tumor Biomarkers (Tumor Markers)IBA
01/2022 - 12/2010
4PlatinumIBA
12/2021 - 10/2007
4Drug CarriersIBA
02/2019 - 01/2011
3Protein Subunit VaccinesIBA
04/2024 - 05/2019
3AntibodiesIBA
01/2024 - 01/2021
3anlotinibIBA
01/2024 - 01/2022
3Angiogenesis InhibitorsIBA
01/2023 - 06/2013
3Trastuzumab (Herceptin)FDA Link
01/2023 - 04/2014
3130-nm albumin-bound paclitaxelIBA
01/2022 - 01/2022
3LipidsIBA
01/2022 - 01/2018
3Circulating Tumor DNAIBA
01/2022 - 04/2017
3Phosphotransferases (Kinase)IBA
08/2021 - 08/2010
3apatinibIBA
01/2020 - 07/2016
3Fibroins (Fibroin)IBA
01/2020 - 01/2016
3Long Noncoding RNAIBA
01/2020 - 01/2019
3Thymidylate SynthaseIBA
02/2014 - 09/2012
3AlkaloidsIBA
08/2013 - 08/2010
3GelatinIBA
03/2012 - 06/2011
3MicellesIBA
08/2008 - 06/2007

Therapy/Procedure

83Therapeutics
05/2024 - 05/2009
47Drug Therapy (Chemotherapy)
04/2024 - 10/2007
46Immunotherapy
07/2024 - 01/2017
31Radiotherapy
04/2024 - 01/2015
11Chemoradiotherapy
01/2023 - 01/2013
5Neoadjuvant Therapy
01/2022 - 12/2014
4Injections
07/2024 - 02/2019
4Aftercare (After-Treatment)
01/2024 - 01/2019
4Cell- and Tissue-Based Therapy (Cell Therapy)
11/2022 - 01/2018
4Gastrectomy
07/2022 - 12/2014
3Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2020 - 08/2012